This inventor holds 12 USPTO granted patents and 1 EPO patent. Top assignees: Pharmacia & Upjohn Company, The Upjohn Co., Eli Lilly and Company. Active years: 1993-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Alingas, SE (1993)
- Alingsas, SE (1994)
- Goteborg, SE (1995 - 1997)
- Portage, MI (US) (1997 - 2003)
Company Filing History:



Years Active: 1993-2025
Title: Innovations in Parkinson's Disease Treatment by Kjell A Svensson
Introduction
Kjell A Svensson, an accomplished inventor based in Portage, MI, has made significant contributions to the field of medical science with a focus on treating neurological disorders. With a total of 11 patents to his name, Svensson has dedicated his career to developing effective therapies for patients suffering from Parkinson's disease.
Latest Patents
Among his latest inventions is a groundbreaking method of treating Parkinson's disease that aims to prevent the development of dyskinesias in patients. This method involves administering a pharmacologically effective amount of a substituted phenylazacycloalkane, along with a dopamine agonist, to the patient. Additionally, it includes the innovative step of transplanting dopamine neurons into the patient's brain. These patented methods reflect his commitment to improving the quality of life for those afflicted with this debilitating condition.
Career Highlights
Svensson's professional journey spans influential roles at well-known companies such as The Upjohn Company and Pharmacia & Upjohn Company. His expertise in the field has not only led to numerous patents but has also positioned him as a key contributor to advancements in pharmacology.
Collaborations
Throughout his career, Kjell A Svensson has collaborated with esteemed professionals, including Per A Carlsson and Bengt R Andersson. These partnerships have played a vital role in the development and refinement of his innovative approaches to treating Parkinson's disease.
Conclusion
Kjell A Svensson's dedication to innovation in the treatment of neurological disorders has established him as a notable inventor in the field. His patents and collaborations reflect a deep commitment to advancing medical science, offering hope and improved outcomes for patients with Parkinson's disease. As he continues to innovate, the impact of his work will undoubtedly benefit countless individuals in the years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile